Stockscreener 앱 받기
176.50
1.02%
1.78
전일 마감가:
$174.72
열려 있는:
$176.29
하루 거래량:
332.90K
Relative Volume:
0.90
시가총액:
$18.79B
수익:
$3.32B
순이익/손실:
$-860.46M
주가수익비율:
-10.57
EPS:
-16.6978
순현금흐름:
$-1.04B
1주 성능:
-1.59%
1개월 성능:
-9.14%
6개월 성능:
+13.48%
1년 성능:
+0.71%
1일 변동 폭
$175.80
$179.25
1주일 범위
$170.99
$180.00
52주 변동 폭
$126.97
$248.16
Beigene Ltd Adr Stock (BGNE) Company Profile
명칭
Beigene Ltd Adr
전화
13459494123
주소
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
BGNE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGNE
Beigene Ltd Adr
|
176.50 | 18.79B | 3.32B | -860.46M | -1.04B | -8.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Beigene Ltd Adr Stock (BGNE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-03 | 재개 | Morgan Stanley | Overweight |
| 2024-09-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-02-06 | 재개 | JP Morgan | Overweight |
| 2023-09-12 | 개시 | Macquarie | Outperform |
| 2023-08-17 | 개시 | Jefferies | Buy |
| 2023-07-17 | 개시 | Citigroup | Buy |
| 2023-06-30 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 개시 | Daiwa Securities | Buy |
| 2022-10-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-10-13 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 재개 | JP Morgan | Overweight |
| 2022-03-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 개시 | Deutsche Bank | Buy |
| 2021-10-12 | 개시 | Bernstein | Outperform |
| 2021-10-06 | 업그레이드 | CLSA | Underperform → Buy |
| 2021-03-08 | 개시 | China Renaissance | Buy |
| 2021-03-01 | 다운그레이드 | CLSA | Outperform → Underperform |
| 2020-11-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-11-06 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2020-07-10 | 다운그레이드 | CLSA | Buy → Outperform |
| 2020-03-13 | 업그레이드 | Macquarie | Underperform → Neutral |
| 2020-02-18 | 재개 | Goldman | Buy |
| 2020-01-17 | 업그레이드 | CLSA | Outperform → Buy |
| 2020-01-17 | 재개 | Morgan Stanley | Overweight |
| 2019-12-16 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-12-16 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-11-19 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-11-13 | 다운그레이드 | CLSA | Buy → Outperform |
| 2019-11-04 | 재확인 | Maxim Group | Buy |
| 2019-06-04 | 개시 | Bernstein | Outperform |
| 2019-05-10 | 업그레이드 | CLSA | Outperform → Buy |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-01-04 | 다운그레이드 | CLSA | Buy → Outperform |
| 2018-11-21 | 개시 | JP Morgan | Overweight |
| 2018-09-25 | 개시 | Leerink Partners | Outperform |
| 2018-05-17 | 재확인 | Maxim Group | Buy |
모두보기
Beigene Ltd Adr 주식(BGNE)의 최신 뉴스
BeiGene shares reiterate Buy rating on robust oncology pipeline - Investing.com
Weekly Upgrades and Downgrades - InvestorPlace
Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio? - Benzinga
Beigene directors sell shares worth $194.2 million - Investing.com
Beigene president Wu Xiaobin reports $120,894 sale of economic interest By Investing.com - Investing.com South Africa
Beigene president Wu Xiaobin reports $120,894 sale of economic interest - Investing.com
Beigene sees $3.57 billion stock sale by Hillhouse Investment By Investing.com - Investing.com South Africa
Beigene sees $274 million stock sale by Hillhouse Investment By Investing.com - Investing.com
AGFA Gevaert NV (AGFB.BR) Stock Price, News & Analyst Forecast - eToro
Morgan Stanley increases BeiGene stock target on drug prospects - Investing.com
10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey
Beigene's Wang Xiaodong sells shares worth $9.19 million - Investing.com
BeiGene stock outlook positive as Bernstein lifts price target, keeps Market Perform - Investing.com
China ADRs have increased to the largest share since late 2021 – GS - MSN
BeiGene settles patent litigation, extends BRUKINSA exclusivity - Investing.com
10 Biggest Biotechnology Companies - Investopedia
BeiGene announces name change to BeOne Medicines Ltd. - Investing.com
BeiGene shares lift on raised price target to $260 from $254 - Investing.com
UBS Raises BeiGene (BGNE.US) TP to US$289.7 as 3Q Results Beat - AASTOCKS.com
BeiGene shares fall despite better-than-expected Q3 results - Investing.com
BeiGene announces passing of board member Donald Glazer - Investing.com
BEIGENE Senior Staff Reportedly Investigated, but Not Related to Firm Operations - AASTOCKS.com
Indaptus Therapeutics partners with BeiGene for cancer study - Investing.com India
BeiGene stock momentum builds on Brukinsa success, says JPMorgan's Fye - Investing.com
CMBI Eyes Opportunities in Innovative Medical Insurance, Prefers WuXi AppTec/ BeiGene/ INNOVENT BIO/ SKB BIO-B/ GIANT BIOGENE/ 3SBIO/ Mindray Bio-MedicalUS StocksGlobal News Content - AASTOCKS.com
Financial Fitness Check: Examining BeiGene Ltd ADR (BGNE)’s Key Ratios - The Dwinnex
The Potential Rise in the Price of BeiGene Ltd ADR (BGNE) following insiders activity - Knox Daily
Samsara Inc (IOT) may enjoy gains as insiders got busy in the recent days - Knox Daily
Monitoring Ginkgo Bioworks Holdings Inc (DNA) after recent insider movements - Knox Daily
Insider Sale Alert: PepsiCo Inc [PEP] – Is it Time to sell? - Knox Daily
VZIO (VIZIO Holding Corp) may reap gains as insiders became active recently - Knox Daily
Investing in Allegro Microsystems Inc. (ALGM) Is Getting More Attractive - Knox Daily
Investing in Alphatec Holdings Inc (ATEC): What You Must Know - Knox Daily
An Analysis of Mercury Systems Inc (MRCY)’s Potential Price Growth - Knox Daily
XPeng Inc. Sponsored ADR (XPEV) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
BeiGene CEO John Oyler sells shares worth over $3.75 million - Investing.com
Royal Caribbean Group [RCL] Shares Rise 5.26 % on Wednesday - Knox Daily
Selling Buzz: UL Solutions Inc [ULS] 10% Owner ULSE Inc. sells 3,000,000 shares of the company - Knox Daily
Director Cui Xiangmin acquire 277,895 shares of Nuvation Bio Inc [NUVB] - Knox Daily
Taking a look at what insiders are doing to gauge the BeiGene Ltd ADR (BGNE)’s direction - Knox Daily
Stock Performance Spotlight: BeiGene Ltd ADR (BGNE) Ends the Day at 240.40, Up by 2.11 - The Dwinnex
Buying Buzz: Vuzix Corporation [VUZI] Director Harned Timothy Heydenreich purchases 20,000 shares of the company - Knox Daily
A company insider recently sold 1,447 shares of uniQure N.V. [QURE]. Should You Sale? - Knox Daily
Director Stark Eugene S acquire 2,500 shares of Prospect Capital Corp [PSEC] - Knox Daily
It makes sense and dollars to buy BeiGene Ltd ADR (BGNE) stock - SETE News
Recent Insider Activity Could Benefit ACI Worldwide Inc (ACIW) - Knox Daily
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Beigene Ltd Adr (BGNE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Beigene Ltd Adr 주식 (BGNE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Dec 10 '24 |
Option Exercise |
6.50 |
41,760 |
271,440 |
41,760 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Dec 10 '24 |
Sale |
186.90 |
41,760 |
7,805,106 |
0 |
| BAKER BROS. ADVISORS LP | Director |
Dec 09 '24 |
Sale |
187.27 |
1,037,017 |
194,200,043 |
791,493 |
0.16%
2.65%
자본화:
|
볼륨(24시간):